Zoeken
Zoeken kan via de modus 'eenvoudig zoeken' (één veld) of uitgebreid via 'geavanceerd zoeken' (meerdere velden). Zo kan je bv. zoeken op een combinatie van een auteursnaam (auteur), een jaartal (jaar) en een documenttype.
Boekenmand
Nuttige resultaten kan je aanvinken en toevoegen aan een mandje. De inhoud hiervan kan je exporteren of afdrukken (naar bv. PDF).
RSS
Op de hoogte blijven van nieuw toegevoegde publicaties binnen uw interessegebied? Dit kan door een RSS-feed (?) te maken van jouw zoekopdracht.
nieuwe zoekopdracht
Structural characterization and cytotoxic activity evaluation of Ulvan polysaccharides extracted from the green algae Ulva papenfussii
Tran, V.H.N.; Mikkelsen, M.D.; Truong, H.B.; Vo, H.N.M.; Pham, T.D.; Cao, H.T.T.; Nguyen, T.T.; Meyer, A.S.; Thanh, T.T.T.; Van, T.T.T. (2023). Structural characterization and cytotoxic activity evaluation of Ulvan polysaccharides extracted from the green algae Ulva papenfussii. Mar. Drugs 21(11): 556. https://dx.doi.org/10.3390/md21110556
In: Marine Drugs. Molecular Diversity Preservation International (MDPI): Basel. ISSN 1660-3397; e-ISSN 1660-3397
|   |
| Trefwoorden |
Ulva papenfussii P.H.Hô, 1969 [WoRMS]
Marien/Kust |
| Author keywords |
ulvan; Ulva papenfussii; structural determination; anti-tumorigenic; QSAR modeling |
| Auteurs | | Top |
- Tran, V.H.N.
- Mikkelsen, M.D.
- Truong, H.B.
- Vo, H.N.M.
|
- Pham, T.D.
- Cao, H.T.T.
- Nguyen, T.T.
|
- Meyer, A.S.
- Thanh, T.T.T.
- Van, T.T.T.
|
| Abstract |
Ulvan, a sulfated heteropolysaccharide with structural and functional properties of interest for various uses, was extracted from the green seaweed Ulva papenfussii. U. papenfussii is an unexplored Ulva species found in the South China Sea along the central coast of Vietnam. Based on dry weight, the ulvan yield was ~15% (w/w) and the ulvan had a sulfate content of 13.4 wt%. The compositional constitution encompassed L-Rhamnose (Rhap), D-Xylose (Xylp), D-Glucuronic acid (GlcAp), L-Iduronic acid (IdoAp), D-Galactose (Galp), and D-Glucose (Glcp) with a molar ratio of 1:0.19:0.35:0.52:0.05:0.11, respectively. The structure of ulvan was determined using High-Performance Liquid Chromatography (HPLC), Fourier Transform Infrared Spectroscopy (FT-IR), and Nuclear Magnetic Resonance spectroscopy (NMR) methods. The results showed that the extracted ulvan comprised a mixture of two different structural forms, namely (“A3s”) with the repeating disaccharide [→4)-β-D-GlcAp-(1→4)-α-L-Rhap 3S-(1→]n, and (“B3s”) with the repeating disaccharide [→4)-α-L-IdoAp-(1→4)-α-L-Rhap 3S(1→]n. The relative abundance of A3s, and B3s was 1:1.5, respectively. The potential anticarcinogenic attributes of ulvan were evaluated against a trilogy of human cancer cell lineages. Concomitantly, Quantitative Structure–Activity Relationship (QSAR) modeling was also conducted to predict potential adverse reactions stemming from pharmacological interactions. The ulvan showed significant antitumor growth activity against hepatocellular carcinoma (IC50 ≈ 90 µg/mL), human breast cancer cells (IC50 ≈ 85 µg/mL), and cervical cancer cells (IC50 ≈ 67 µg/mL). The QSAR models demonstrated acceptable predictive power, and seven toxicity indications confirmed the safety of ulvan, warranting its candidacy for further in vivo testing and applications as a biologically active pharmaceutical source for human disease treatment. |
IMIS is ontwikkeld en wordt gehost door het VLIZ.
